SCHEMBL4923926

SCHEMBL4923926

N#Cc1ccc(-c2cc(Nc3c(NCc4cccc(O)c4)c(=O)c3=O)ccc2O)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 2/20 0.41
AURKB Q96GD4 6/20 0.40
RPS6KB1 P23443 5/20 0.40
ROCK2 O75116 4/20 0.40
CHEK2 O96017 4/20 0.40
PRKACA P17612 4/20 0.40
AKT1 P31749 4/20 0.40
GSK3B P49841 4/20 0.40
RPS6KA3 P51812 4/20 0.40
ROCK1 Q13464 4/20 0.40
PRKG1 Q13976 4/20 0.40
PKN2 Q16513 4/20 0.40
CDC42BPA Q5VT25 4/20 0.40
HIPK4 Q8NE63 4/20 0.40
CHEK1 O14757 3/20 0.40
AKT2 P31751 3/20 0.40
CLK2 P49760 3/20 0.40
PRKAA1 Q13131 3/20 0.40
PRKG2 Q13237 3/20 0.40
CLK4 Q9HAZ1 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4916802 0.83 AURKB (0.47) AURKBRPS6KB1ROCK2CHEK2PRKACA
SCHEMBL4598269 0.83 KDM1A (0.46) AURKBRPS6KB1ROCK2CHEK2PRKACA
SCHEMBL4917160 0.83 MAPKAPK2 (0.53) CXCR2AURKBMAPK1CSNK1G1MAPKAPK2
SCHEMBL4924083 0.83 MAPKAPK2 (0.53) CXCR2AURKBMAPK1CSNK1G1MAPKAPK2
SCHEMBL4923578 0.83 MAPKAPK2 (0.53) CXCR2AURKBMAPK1CSNK1G1MAPKAPK2
SCHEMBL4919519 0.82 GSK3B (0.45) AURKBRPS6KB1ROCK2CHEK2PRKACA
SCHEMBL4596918 0.80 GSK3B (0.46) AURKBRPS6KB1ROCK2CHEK2PRKACA
SCHEMBL4920693 0.79 RPS6KB1 (0.41) CXCR2AURKBRPS6KB1ROCK2CHEK2
SCHEMBL4920357 0.79 KDM4C (0.42) CXCR2AURKBRPS6KB1ROCK2CHEK2
SCHEMBL4917249 0.79 GSK3B (0.43) AURKBRPS6KB1ROCK2CHEK2PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312244-A1 Squaric Acid Derivatives as Protein Kinase Inhibitors MERCK PATENT GMBH (DE) 2008-12-18 US claimed
US-20080312244-A1 Squaric Acid Derivatives as Protein Kinase Inhibitors MERCK PATENT GMBH (DE) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312244-A1 Squaric Acid Derivatives as Protein Kinase Inhibitors CHEK1, CHEK2, SIK1 CXCR2 2404/4885AURKB 78/4885RPS6KB1 276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.